ZHANG Yong-xue, PU Ze-yao, AN Ya-ting, ZHANG Wei, WANG Yi-ying, HAO Han, ZHANG Hui-ran, ZHANG Hai-lin, DU Xiao-na. Research progress of PDI in amyotrophic lateral sclerosisJ. Acta Pharmaceutica Sinica, 2021,56(10): 2735-2741. doi: 10.16438/j.0513-4870.2021-0686
Citation: ZHANG Yong-xue, PU Ze-yao, AN Ya-ting, ZHANG Wei, WANG Yi-ying, HAO Han, ZHANG Hui-ran, ZHANG Hai-lin, DU Xiao-na. Research progress of PDI in amyotrophic lateral sclerosisJ. Acta Pharmaceutica Sinica, 2021,56(10): 2735-2741. doi: 10.16438/j.0513-4870.2021-0686

Research progress of PDI in amyotrophic lateral sclerosis

  • Protein disulfide isomerase (PDI), also named PDIA1, is an archetype member of protein disulfide isomerase family, which mainly exists in endoplasmic reticulum and plays an important role in pathophysiological progress via enzyme activity and molecular chaperone function helping protein folding correctly. Amyotrophic lateral sclerosis (ALS) is a kind of neurodegenerative diseases characterized by abnormal protein aggregation. Recently, PDI mutants have been found in ALS patients and the important role of PDI protein in the development of ALS has also been confirmed. Here, we focus on the recent studies of PDI in ALS hoping to provide a novel target for the treatment of ALS.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return